0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV963.83%PremiumMay 17, 2024Expiry Date6.80Intrinsic Value100Multiplier-7DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Kezar Life Sciences Stock Discussion
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences(KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences(KZR.US)$
$LumiraDx(LMDX.US)$
Top Medical News of the Week
Merck Q3 earnings top Wall Street’s expectations
Merck stock surged within a buy zone Thursday after the pharma giant notched a third-quarter beat on particularly strong performances from Keytruda and Gardasil.
Revenue from blockbuster cancer drug Keytruda soared 20% during the quarter, leading a ...
• $Kezar Life Sciences(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $Trip.com(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical(APYX.US)$ +8% (anno...
• $Livent(LTHM.US)$ +22.58% (it posted better-than-expected quarterly earnings and raised its 2022 revenue forecast)
• $Super Micro Computer(SMCI.US)$ +11.01% (earnings reports)
• $Oatly Group AB(OTLY.US)$ +8.31% (earnings reports)
• $BlueLinx Holdings(BXC.US)$ +9.7% (increases share repurchase authorization to $100 mln; enters into $60 mln accelerated repurchase agreement)
• $Starbucks(SBUX.US)$ +7.18% (matched estimates wi...
$Kezar Life Sciences(KZR.US)$ is in an uptrend after last Tuesday's PR. adding above $14.
$QuantumScape(QS.US)$ bouncing off $34 support. Possible chance of reversal here. Looking for break of $35 to add
$PLBY Group(PLBY.US)$ seeing some $50 call activity. Resistance at $41.50, good to add above it.
$Plug Power(PLUG.US)$ got analyst price target of $65 on friday. Good to add above $45.
No comment yet